Literature DB >> 20428807

Created Gli-1 duplex short-RNA (i-Gli-RNA) eliminates CD44 Hi progenitors of taxol-resistant ovarian cancer cells.

Takashi Mine1, Satoko Matsueda, Hui Gao, Yufeng Li, Kwong-Kwok Wong, George E Peoples, Soldano Ferrone, Constantin G Ioannides.   

Abstract

Notch and Hedgehog activate cell-cycle progression of adult and cancer stem cells. Notch is activated by DLL and Jag presents on neighboring cells. We investigated the effects of density of the Notch-activating ligand, Jag-1, and targeting Gli-1, in activation of division of paclitaxel/taxol-resistant, (PTX Res) ovarian cancer cells SKOV3 (SKOV3). We used the specific gamma-presenilin inhibitor, DAPT, to identify the specificity of activating signals for Notch-1 and created 'butterfly-duplex-3548-Gli-1-inhibitory RNA' (i-Gli-1.RNA) to inhibit cell division. To accurately quantify kinetics of division, the expression of CD44 and CD24 was determined in each gated population of divided cells. CD44 High proliferated when activated by Jag-1 Low and poorly when activated by Jag-1 High. DAPT inhibited proliferation of cells activated by Jag-1 Low, and increased proliferation of cells activated by Jag-1 High. Only 5-10% of cells activated by Jag-1 High and Jag-1 Low divided fast, polynomial, and symmetric. i-Gli-1.RNA eliminated more than 50% of the small CD44 High/CD24 Neg cells in divisions 3 and 4. This effect appeared specific compared with cells transfected with negative control siRNA. i-Gli-1.RNA had no effect on large CD44 High/CD24 Neg cells, but inhibited the population of CD44 High/CD24 Low cells. Expansion of CD44 High inversely correlated with Jag-1 density on activating autologous tumor and fibrosarcoma cells. Created i-RNAs may decrease the resting CSC pool. Notch and Gli-1 signals play an important role in proliferation/division and survival of cancer stem cells. Targeting Notch-1 through its enhancer Gl-1, should be significant for novel treatments to eliminate taxol-resistant cancer stem cells (CSC). i.Gli-1 RNA should be more effective if used together with Taxol.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20428807      PMCID: PMC3426036          DOI: 10.3892/or_00000793

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  28 in total

1.  Sensitivity of undifferentiated, high-TCR density CD8+ cells to methylene groups appended to tumor antigen determines their differentiation or death.

Authors:  Kouichiro Kawano; Clay L Efferson; George E Peoples; Darrick Carter; Naotake Tsuda; James L Murray; Constantin G Ioannides
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

2.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

3.  Induction of tumor-reactive CTL by C-side chain variants of the CTL epitope HER-2/neu protooncogene (369-377) selected by molecular modeling of the peptide: HLA-A2 complex.

Authors:  Agapito Castilleja; Darrick Carter; Clay L Efferson; Nancy E Ward; Kouichiro Kawano; Bryan Fisk; Andrzej P Kudelka; David M Gershenson; James L Murray; Catherine A O'Brian; Constantin G Ioannides
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

4.  Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling.

Authors:  Pilar Sanchez; Ana Maria Hernández; Barbara Stecca; Andrea J Kahler; Amy M DeGueme; Andrea Barrett; Mercedes Beyna; Milton W Datta; Sumana Datta; Ariel Ruiz i Altaba
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

5.  Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells.

Authors:  Takashi Mine; Satoko Matsueda; Yufeng Li; Hiroshi Tokumitsu; Hui Gao; Cristopher Danes; Kwong-Kwok Wong; Xinhui Wang; Soldano Ferrone; Constantin G Ioannides
Journal:  Cancer Immunol Immunother       Date:  2008-12-02       Impact factor: 6.968

6.  BRCA1 regulates human mammary stem/progenitor cell fate.

Authors:  Suling Liu; Christophe Ginestier; Emmanuelle Charafe-Jauffret; Hailey Foco; Celina G Kleer; Sofia D Merajver; Gabriela Dontu; Max S Wicha
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

7.  Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells.

Authors:  Lilly Y W Bourguignon; Karine Peyrollier; Weiliang Xia; Eli Gilad
Journal:  J Biol Chem       Date:  2008-04-25       Impact factor: 5.157

8.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

9.  Identification and characterization of ovarian cancer-initiating cells from primary human tumors.

Authors:  Shu Zhang; Curt Balch; Michael W Chan; Hung-Cheng Lai; Daniela Matei; Jeanne M Schilder; Pearlly S Yan; Tim H-M Huang; Kenneth P Nephew
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

10.  Cell biology of stem cells: an enigma of asymmetry and self-renewal.

Authors:  Haifan Lin
Journal:  J Cell Biol       Date:  2008-01-28       Impact factor: 10.539

View more
  7 in total

1.  Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.

Authors:  Adam D Steg; Ashwini A Katre; Blake Goodman; Hee-Dong Han; Alpa M Nick; Rebecca L Stone; Robert L Coleman; Ronald D Alvarez; Gabriel Lopez-Berestein; Anil K Sood; Charles N Landen
Journal:  Clin Cancer Res       Date:  2011-07-13       Impact factor: 12.531

Review 2.  Targeting Notch signaling pathway to overcome drug resistance for cancer therapy.

Authors:  Zhiwei Wang; Yiwei Li; Aamir Ahmad; Asfar S Azmi; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2010-06-22

3.  Delta/notch-like epidermal growth factor-related receptor (DNER) orchestrates stemness and cancer progression in prostate cancer.

Authors:  Lijun Wang; Qi Wu; Shan Zhu; Zhiyu Li; Jingping Yuan; Dehua Yu; Zhiliang Xu; Juanjuan Li; Shengrong Sun; Changhua Wang
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 4.  Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells.

Authors:  Weiqiang Zhou; Guangdi Wang; Shanchun Guo
Journal:  Biochim Biophys Acta       Date:  2013-10-30

5.  Collagen complexes increase the efficiency of iPS cells generated using fibroblasts from adult mice.

Authors:  Byung-Soo Chang; Yun-Jung Choi; Jin-Hoi Kim
Journal:  J Reprod Dev       Date:  2015-02-03       Impact factor: 2.214

6.  CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.

Authors:  Samantha Wei-Man Lun; Siu Tim Cheung; Phyllis Fung Yi Cheung; Ka-Fai To; John Kong-Sang Woo; Kwong-Wai Choy; Chit Chow; Chartia Ching-Mei Cheung; Grace Tin-Yun Chung; Alice Suk-Hang Cheng; Chun-Wai Ko; Sai-Wah Tsao; Pierre Busson; Margaret Heung-Ling Ng; Kwok-Wai Lo
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

7.  GLI1 upregulates C-JUN through a specific 130-kDa isoform.

Authors:  Lauren Amable; Elaine Gavin; Kenji Kudo; Erhong Meng; Rodney P Rocconi; Lalita A Shevde; Eddie Reed
Journal:  Int J Oncol       Date:  2013-12-20       Impact factor: 5.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.